CClinicalTrials.gg
Status unknownNCT05811819Updated Apr 13, 2023

Hand Training & Brain Changes

An interventional study of Treatment using the MyHand System in Stroke and Hand Function, sponsored by IRegained Inc.. Status unknown at 1 site in Canada. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-04-13.

Sponsored by IRegained Inc. · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 100 Years
Sex
All
01

Study summary

10 participants with upper-limb impairment will be recruited from community sources. They will be invited to participate in a 15-day trial involving the IRegained device. The study will involve 2 assessment visits to McMaster, before and after the treatment, and 15 treatment visits. The data from the pilot study will be analyzed both quantitatively and qualitatively, as outcomes and explicit feedback from participants will be used to further optimize the device for future studies.

Read the detailed description

This pilot study will investigate the potential changes in the brain area controlling hand movement following 15 days of exercises to improve hand function in participants with upper limb impairments resulting from stroke. A device developed by Dr. Vineet Johnson (IRegained Inc.) will be used to administer standardized exercises to improve hand function. To assess brain changes, transcranial magnetic stimulation pulses will be delivered to the motor cortex. The motor evoked potential (MEP), a muscle response evoked from the TMS, will be measured using electrodes on the hand. This study will test the feasibility of conducting motor therapy using this device while assessing potential changes in motor cortex function. Findings from this study will contribute to developing treatment trials aimed at improving impaired limb function in stroke patients and quality of life in these individuals

02

Conditions studied

  • Stroke
  • Hand Function

Keywords

  • Hand Function
  • Rehabilitation
  • stroke rehabilitation
  • Motor control
  • Hand Rehabilitation
  • Neurorehabilitation
03

In context

Lead sponsor

IRegained Inc. is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

-Sustained a single stroke >6months prior to start of study

Exclusion criteria

Exclusion Criteria:

  • Severe spasticity or contractures (2 or less in the CMSA)
  • any other musculoskeletal or neuromuscular disorders that compromise sensation
  • Prospective participants who are incapable of providing consent to participate in the research study will also be excluded (determined by an MMSE score of 23 or less).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Neurorehabilitation of the Hand

    Participants will undergo a 1-hour training session 5 days per week, over 3 weeks for a total of 15 sessions. Hand function therapy will be administered using the gamified protocol to enhance rehabilitation of the hand and provide participants with greater opportunity to regain hand function over the course of the study.

    Device: Treatment using the MyHand System

Interventions

  • DeviceTreatment using the MyHand System

    Participants will undergo three weeks of 1-hour hand therapy with the MyHand System. The MyHand System provides a highly unique and targeted approach to hand function rehabilitation with the help of the aforementioned protocols delivered with gamified training techniques. The gamified format of the protocols allows for better patient engagement, thus allowing for more effective and efficient therapy.

06

What researchers measure

Primary outcomes

  1. Chedoke Arm and Hand Activity Inventory 9 (CAHAI-9)- Change is being assessed

    a 9-item assessment, will be performed by a trained clinician to estimate a participants functional ability during the initial assessment. The CAHAI-9 requires a participant to perform 9 bimanual ADLs, each of which will be scored on a 7 point scale.

    Time frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days

  2. ABILHAND- Change is being assessed

    a subjective functional assessment tool will be used. The tool is a 23-item survey, and participants are provided with a list of various everyday functional tasks and are scored based on patient response. For example, participant will be asked whether it is 'easy', 'difficult' or 'impossible' for each of the 23 tasks.

    Time frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days

  3. Box and Block (BBT)- Change is being assessed

    The BBT requires participants to move cubical wooden blocks over a partition from one box to another. Grip and pinch dynamometry will be used to assess a participant's hand strength.

    Time frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days

Secondary outcomes

  1. Finger Goniometry- Change is being assessed

    Estimate range of motion (ROM) of the various finger joints.

    Time frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days

  2. Grip Dynamometry- Change is being assessed

    Measures participants grip strength

    Time frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days

  3. Pinch Dynamometry- Change is being assessed

    Measures participants pinch strength

    Time frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 15 treatment sessions, within 5 days

07

Study locations

1 of 1 sites recruiting
  • Aimee Nelson
    Hamilton, Ontario L8L 8E7, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05811819
Lead sponsor
IRegained Inc.
Collaborators
Baycrest, McMaster University
Responsible party
Sponsor
First posted
Apr 13, 2023
Start date
Oct 19, 2022
Primary completion
Jul 9, 2023 (estimated)
Completion
Jul 9, 2023 (estimated)
Last update
Apr 13, 2023

Study contacts

Ravjot Rehsi, MSc
Contact
rehsir@mcmaster.ca
9052996418
Mikayla Marshall
Contact
mikayla@iregained.ca
2898088821
Aimee Nelson, PhD
principal investigator · McMaster University
Jed Meltzer, PhD
study director · Baycrest Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion